In a mental health system where waitlists can stretch for months, LeapForward.AI is trying to insert a digital first responder. The Sydney-based startup offers a six-week program delivered by an AI companion named Lucy, designed to provide immediate, daily support for people recovering from injury or illness [LeapForward.ai].
The Wedge of Immediate Access
LeapForward’s core product is a structured digital course. Users receive daily guidance from Lucy, which delivers short videos and practical, evidence-based strategies [LeapForward.ai]. Founder Libby Roberts, a psychologist, developed the approach from personal experience [DigitalHealth.London]. The company reports a 98% improvement in wellbeing scores and a 77% engagement rate [LeapForward.ai].
A Business Model Built for Payers
From its inception in 2019, LeapForward has targeted a business-to-business model, selling its program to insurers and corporate employers [Prospeo]. The company reports it has secured five of Australia’s major insurers as customers, and has announced partnerships with specific providers like Southern Cross and QBE [Loyal VC, Mirage News]. Revenue is reported at approximately $90,000 per month [Loyal VC, Prospeo].
| Role | Name |
|---|---|
| Founder & CEO | Libby Roberts |
| CEO & Director | Craig Walter Roberts |
The company’s operational footprint remains modest, with an estimated 1-10 employees and no disclosed external funding rounds [Prospeo]. It participated in the Founder Institute Sydney accelerator and counts Loyal VC in its portfolio [Founder Institute, Loyal VC].
Navigating a Crowded and Cautious Field
- Clinical validation. While the company cites “clinically validated” methods, these figures lack third-party audit or peer-reviewed publication [LeapForward.ai].
- AI as clinician. The program is designed as a guided tool, not a replacement for a human therapist, and offers optional weekly telehealth sessions [LeapForward.ai].
- Market expansion. Scaling beyond the Australian insurance market would require navigating different regulatory regimes and sales cycles.
The company’s next twelve months will likely be defined by its ability to convert early insurer partnerships into durable, expanding contracts, and to begin the process of generating external validation for its reported outcomes.